Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Xyall secures €6 million Series B financing to spearhead commercialization of its automated tissue dissector
, /in E-News /by panglobalXyall, a global innovator in molecular pathology, has attracted a Series B investment of €6 million to accelerate commercialization of its Tissector High Throughput and Tissector Table Top systems.
KNAUER wins German Innovation Award 2022
, /in E-News /by panglobalKNAUER Wissenschaftliche Geräte, a developer of laboratory instruments and known for their liquid chromatography systems and components, was honoured with the German Innovation Award 2022 in Munich in April for their design and manufacture of large-scale plants, at its own risk, for the ncapsulation of mRNA for COVID-19 vaccines. Equipment for the production of millions of mRNA vaccine doses had […]
Greiner Bio-One appoints new head of business for Preanalytics
, /in E-News /by panglobalDr Stefan Gebauer has taken over management of the “Preanalytics” product division at Greiner Bio-One in Kremsmünster, Austria. He has many years of professional and management experience in the healthcare industry, focussing primarily on medical products in the IVD sector. Before joining Greiner Bio-One, he successfully managed the “Therapy Management” product line at Bosch Healthcare […]
Agilent companion diagnostic expands CE-IVD Mark in Europe to include cervical cancer
, /in E-News /by panglobalAgilent Technologies says its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC 22C3 pharmDx can be used as an aid in identifying cervical cancer patients for whom treatment with KEYTRUDA (pembrolizumab) may be appropriate.
Aptamer Group and PinotBio extend collaboration for the development of Optimer-drug conjugates
, /in E-News /by panglobalAptamer Group, the developer of novel Optimer binders to enable innovation in the life sciences industry, has extended its collaboration agreement with PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, to develop four new Optimer-drug conjugates for use as precision chemotherapeutics.
Avacta establishes new Therapeutics HQ at Scale Space science cluster in London
, /in E-News /by panglobalAvacta Group, a clinical stage oncology drug company developing cancer therapies and diagnostics based on its proprietary pre|CISION and Affimer platforms, has relocated its Therapeutics division to a new headquarters at Scale Space, in Imperial College’s White City Campus, London.
Diasys
, /in Advertenties /by panglobalnovabiomedical
, /in Advertenties /by panglobalquantimetrix
, /in Advertenties /by panglobalCAP
, /in Advertenties /by panglobal